BSE filing, NSE: MEGRISOFT. Summary written from the filing by ALFA Finder's alert engine.
Megri Soft Ltd: key numbers
- Share price
- ₹78.93
- Market cap
- ₹24.79 Cr
- Revenue (annual)
- ₹2.92 Cr
- Net profit (annual)
- ₹0.62 Cr
- P/E (TTM)
- 40.9×Sector 23.0×
- Promoter holding
- 74.99%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Megri Soft Ltd
All →Megri Soft Q2 FY27 Results: Net Profit ₹0 Cr
Megri Soft Ltd reported revenue from operations of ₹1.1 Cr (+57.1% YoY) and net profit of ₹0 Cr for Q2 FY27.
- Key figure
- Net profit ₹0 Cr
Megri Soft Board Meeting Date
Megri Soft Limited scheduled a Board meeting on October 22, 2026, to consider and approve unaudited financial results for the quarter and half-year ended September 30, 2026.
Megri Soft Merger & Restructuring
Megri Soft's UK subsidiary, Megrisoft Limited, ceased to be a subsidiary following a share allotment that diluted Megri Soft's stake to 14.29%.
Megri Soft Annual General Meeting
Megri Soft Limited held its 35th Annual General Meeting on September 2, 2026. Shareholders discussed and transacted the items of business set out in the AGM notice.
Megri Soft Annual General Meeting
Megri Soft Limited has issued a notice for its 35th Annual General Meeting, which will be held via video conferencing on September 2, 2026.
Megri Soft Q1 FY27 Results: Net Profit ₹0.2 Cr, Up 100.0% YoY
Megri Soft Ltd reported revenue from operations of ₹1 Cr (+42.9% YoY) and net profit of ₹0.2 Cr (+100.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹0.2 Cr · +100.0% YoY
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.